Headquartered in Long Beach, California, Obagi Medical Products, Inc., is a specialty pharmaceutical company that develops, markets and sells, and is the leading provider of, proprietary topical aesthetic and therapeutic clinically-proven skin care systems in the physician-dispense market. The systems are designed to prevent and improve the most common and visible skin disorders in adult skin. The foundation of the company began in 1988 with the creation of the Obagi Nu-Derm^® System, developed by leading skin care experts. In 1997 the company officially began operations as Obagi Medical Products, Inc.

The company has continued to grow each year, introducing multiple product lines and expanding its commercial operations. The company sells its products through a direct sales force in the United States and internationally through distribution partners in over 47 countries across North America, Central America, South America, Europe, the Middle East and Asia.

Over the years, the company has developed clinically-proven skin health products and systems primarily for the dermatology, plastic surgery and related aesthetic markets. Using its Penetrating Therapeutics™ technologies, the company’s products are designed to improve penetration of prescription and cosmetic agents across the skin barrier for common and visible skin conditions in adult skin including premature aging, photodamage, hyperpigmentation (irregular or patchy discoloration of the skin), acne, sun damage, rosacea and soft tissue deficits, such as fine lines and wrinkles.

The Obagi Nu-Derm System consists of topical products, which when used as a system result in substantial improvement to many of these skin related conditions. The company continues to maintain its position as a leader in skin health by having launched several successful new systems of products, including the Obagi-C^® Rx System which is the first prescription-strength Vitamin C and hydroquinone system; the Condition & Enhance™ System, developed to enhance the results of physician delivered surgical and non-surgical procedures; the ELASTIderm^® family of products, a one of a kind treatment developed to restore skin elasticity and collagen production, and reduce fine lines and wrinkles around the eyes and décolletage; CLENZIderm M.D.™ Acne Therapeutic Systems to treat and prevent acne at it’s root; and most recently the Rosaclear™ System, developed specifically for the treatment and prevention of the signs and symptoms of rosacea.

Because Obagi^® Systems and products contain prescription-strength formulations, the systems are only available through physicians, primarily dermatologists, plastic surgeons, medical spas and other skin care and medical specialists.